Blue Owl Capital Holdings’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Blue Owl Capital Holdings’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-21,009	Closed	-$315K	–	45
2022 Q4	$315K	Buy	+21,009	New	+$291K	0.13%	34

Blue Owl Capital Holdings's AVEO Position: Q1 2023 in Review

Blue Owl Capital Holdings sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 21,009 shares — an estimated $315K sold.

Blue Owl Capital Holdings first reported a position in AVEO in Q4 2022 and held it in 1 quarter. The position peaked at $315K in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

Blue Owl Capital Holdings reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
Blue Owl Capital Holdings sold 21,009 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $315K.
Blue Owl Capital Holdings first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
Blue Owl Capital Holdings's AVEO Pharmaceuticals, Inc. position peaked at $315K in Q4 2022.
0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Blue Owl Capital Holdings's 13F filing for Q1 2023, filed 11 May 2023.